Skip to main content

Automation of sample preparation for mass cytometry barcoding in support of clinical research: protocol optimization

Abstract

Analysis of multiplexed assays is highly important for clinical diagnostics and other analytical applications. Mass cytometry enables multi-dimensional, single-cell analysis of cell type and state. In mass cytometry, the rare earth metals used as reporters on antibodies allow determination of marker expression in individual cells. Barcode-based bioassays for CyTOF are able to encode and decode for different experimental conditions or samples within the same experiment, facilitating progress in producing straightforward and consistent results. Herein, an integrated protocol for automated sample preparation for barcoding used in conjunction with mass cytometry for clinical bioanalysis samples is described; we offer results of our work with barcoding protocol optimization. In addition, we present some points to be considered in order to minimize the variability of quantitative mass cytometry measurements. For example, we discuss the importance of having multiple populations during titration of the antibodies and effect of storage and shipping of labelled samples on the stability of staining for purposes of CyTOF analysis. Data quality is not affected when labelled samples are stored either frozen or at 4 °C and used within 10 days; we observed that cell loss is greater if cells are washed with deionized water prior to shipment or are shipped in lower concentration. Once the labelled samples for CyTOF are suspended in deionized water, the analysis should be performed expeditiously, preferably within the first hour. Damage can be minimized if the cells are resuspended in phosphate-buffered saline (PBS) rather than deionized water while waiting for data acquisition.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Abbreviations

CyTOF:

Cytometry by Time-Of-Flight

FB:

Fixation buffer

ICP-MS:

Inductively coupled plasma-mass spectrometry

MCB:

Mass-tag cellular barcoding

PBMC:

Peripheral blood mononuclear cell

PMA:

Phorbol 12-myristate 13-acetate, also known as 12-O-tetradecanoylphorbol-13-acetate (TPA)

SB:

Maxpar Cell Staining Buffer

References

  1. Spitzer MH, Nolan GP. Mass cytometry: single cells, many features. Cell. 2016;165(4):780–91.

    CAS  Article  Google Scholar 

  2. Bendall SC, Simonds EF, Qiu P, et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science. 2011;332(6030):687–96.

    CAS  Article  Google Scholar 

  3. Yao Y, Liu R, Shin MS, Trentalange M, Allore H, Nassar A, et al. CyTOF supports efficient detection of immune cell subsets from small samples. J Immunol Methods. 2014;415:1–5.

    CAS  Article  Google Scholar 

  4. Bandura DR, Baranov VI, Ornatsky OI, et al. Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem. 2009;81(16):6813–22.

    CAS  Article  Google Scholar 

  5. Cheung RK, Utz PJ. Screening: CyTOF-the next generation of cell detection. Nat Rev Rheumatol. 2011;7(9):502–3.

    Article  Google Scholar 

  6. Cosma A, Le Grand R. Brief introduction to mass cytometry. Med Sci (Paris). 2011;27(12):1072–4.

    Article  Google Scholar 

  7. Doerr A. A flow cytometry revolution. Nat Methods. 2011;8(7):531.

    Article  Google Scholar 

  8. Giesen C, Wang HA, Schapiro D, et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods. 2014;4:417–22.

    Article  Google Scholar 

  9. Saadatpour A, Guo G, Orkin SH, et al. Characterizing heterogeneity in leukemic cells using single-cell gene expression analysis. Genome Biol. 2014;15(12):525.

    Article  Google Scholar 

  10. Piccirillo S, Colman S, Potter NE, et al. Genetic and functional diversity of propagating cells in glioblastoma. Stem Cell Reports. 2015. 13;4(1):7–15.

  11. Fu J, Stone NR, Liu L, et al. Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state. Stem Cell Rep. 2013;1(3):235–47.

    CAS  Article  Google Scholar 

  12. Victor M, Richner M, Hermanstyne TO, et al. Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. Neuron. 2014;84(2):311–23.

    CAS  Article  Google Scholar 

  13. Saliba AE, Westermann AJ, Gorski SA, et al. Single-cell RNA-seq: advances and future challenges. Nucleic Acids Res. 2014;42(14):8,845–60.

    CAS  Article  Google Scholar 

  14. Leipold MD, Maecker HT. Mass cytometry: protocol for daily tuning and running cell samples on a CyTOF mass cytometer. J Vis Exp. 2012;2:(69).

  15. Nassar AF, Ogura H, Wisnewski AV. Impact of recent innovations in the use of mass cytometry in support of drug development. Drug Discov Today. 2015;20(10):1169–75.

    CAS  Article  Google Scholar 

  16. Nassar AE, Carter B, Lannigan J et. al. The first multi-center comparative study using a novel technology mass cytometry Time-of-Flight mass spectrometer (CyTOF) for high-speed acquisition of highly multi-parametric single cell data: a status report. CYTO 2015 30th Congress of the International Society for Advancement of Cytometry Scottish Exhibition and Conference Centre Glasgow, Scotland. 2015.

  17. Van der Maaten L, Hinton G. Visualizing data using t-SNE. J Mach Learn Res. 2008;9:2579–605.

    Google Scholar 

  18. Kleinsteuber K, Corleis B, Rashidi N, Nchinda N, Lisanti A, Cho JL, et al. Standardization and quality control for high-dimensional mass cytometry studies of human samples. Cytometry A. 2016;89(10):903–13.

    CAS  Article  Google Scholar 

  19. Qian F, Goel G, Meng H, Wang X, You F. Systems immunology reveals markers of susceptibility to West Nile virus infection. Clin Vaccine Immunol. 2015;22(1):6–16.

    Article  Google Scholar 

  20. Mohanty S, Joshi SR, Ueda I, Wilson J, Blevins TP. Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. J Infect Dis. 2015, 1;211(7):1174–84.

  21. Lindow JC, Wunder EA Jr, Popper SJ, Min JN, et al. Cathelicidin insufficiency in patients with fatal leptospirosis. PLoS Pathog. 2016;12(11).

  22. Nassar AF, Wisnewski AV, Raddassi K. Mass cytometry moving forward in support of clinical research: advantages and considerations. Bioanalysis. 2016;8(4):255–7.

    CAS  Article  Google Scholar 

  23. Nassar AF, Wisnewski AV, Raddassi K. Progress in automation of mass cytometry barcoding for drug development. Bioanalysis. 2016;8(14):1429–35.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This work is supported in part by a grant from Centers for Disease Control and Prevention/The National Institute for Occupational Safety and Health (OH110941). The authors thank the members of the Yale CyTOF user’s group for helpful discussions.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Ala F. Nassar.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nassar, A.F., Wisnewski, A.V. & Raddassi, K. Automation of sample preparation for mass cytometry barcoding in support of clinical research: protocol optimization. Anal Bioanal Chem 409, 2363–2372 (2017). https://doi.org/10.1007/s00216-017-0182-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-017-0182-4

Keywords

  • Multiplexing
  • Barcoding
  • CyTOF
  • Mass cytometry